Evidence map›Paper›PMID 40885850›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Lasting effects of oral contraceptives on fear responses to a safe context.

Lisa-Marie Davignon, Alexandra Brouillard, Marie-France Marin

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hormonal contraceptive effects on the brain: considering the dual impact of endogenous and exogenous hormone flux.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lisa-Marie DavignonResearch Center of the Institut Universitaire en Santé Mentale de Montréal, Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal, 7331 Hochelaga Street, Montreal, QC, Canada.ORCID 0000-0002-3015-5383
Alexandra BrouillardResearch Center of the Institut Universitaire en Santé Mentale de Montréal, Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal, 7331 Hochelaga Street, Montreal, QC, Canada.
Marie-France MarinResearch Center of the Institut Universitaire en Santé Mentale de Montréal, Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal, 7331 Hochelaga Street, Montreal, QC, Canada. marin.marie-france@uqam.ca.ORCID 0000-0003-0297-5680

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 169080Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 493349Réseau en Bio-Imagerie du Quebec (Quebec Bio-Imaging Network) 35450
6 · The paper itself

Abstract

Estradiol (E2), whether endogenous or administered via oral contraceptives (OCs), modulates fear regulation. However, its role in contextual fear signaling, critical for distinguishing threat from safety, remains poorly understood in humans. While prior human studies focused on cue-related extinction recall, animal research suggests that a single high-dose of exogenous E2 generalizes fear to safe contexts. This study tested whether hormonal status and OC use influence contextual fear responses in humans, and whether OC-related effects are long-lasting and dose-dependent. In a two-day fear conditioning and extinction protocol, 147 healthy participants (men, cycling women, OC users) underwent fear conditioning in a threat-associated context (CX + ) and extinction in a safety-associated context (CX-). On day 2, cues were presented in both contexts. Fear return to each context was assessed via skin conductance responses and brain activations. Groups were formed sequentially using the same participants: (A) by endogenous/exogenous E2 status, (B) by OC use history, and (C) by current ethinyl estradiol (EE) dose. CX- fear returns were elevated in current (p = .015, d = 0.64) and past OC users (p = .014, d = 0.83) compared to never users. High-EE, but not low-EE users, showed greater fear returns than never users (p = .021, d = 0.81). Biological sex and endogenous E2 were unrelated to contextual fear. Across participants, CX- fear returns were negatively associated with hippocampal and ventromedial prefrontal cortex activation. OC use, particularly at higher EE doses, may impair retrieval of safety signals from context, with effects persisting beyond discontinuation. These findings highlight exogenous hormones as a modulator of contextual fear regulation in women.

Indexed as

BrainConditioning, ClassicalContraceptives, OralEstradiolEthinyl EstradiolExtinction, PsychologicalFearAdolescentAdultCuesDose-Response Relationship, DrugFemaleGalvanic Skin ResponseHumansMagnetic Resonance ImagingMaleContraceptives, OralEstradiolEthinyl Estradiol

Identifiers

PMID40885850
PMCPMC12708855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.